Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Clinical trial NCT02591420 · COMPLETED
Trial details
- NCT number
- NCT02591420
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2021-03-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.